Curious about the stocks that are showing activity before the opening bell on Thursday?
By Mill Chart
Last update: Apr 18, 2024
Which stocks are moving before the opening bell on Thursday?
Gainers
| Ticker | Change | Comment |
|---|---|---|
| TIRX | 240.0% | Pre-market trading on Thursday showed positive momentum for TIAN RUIXIANG HOLDINGS LTD-A (NASDAQ:TIRX), as the stock price advanced 240.0% to reach $1.65. In the last 6 months the stock lost 44.92%. |
| AGBA | 182.0% | During Thursday's pre-market session, AGBA GROUP HOLDING LTD (NASDAQ:AGBA) experienced a 182.0% increase, with the stock price reaching $1.13. Earlier today the company had a press release: AGBA and Triller Merge to Create a $4 Billion Powerhouse, Unleashing a Game-Changing Power in Digital Content and Financial Services. |
| DCFC | 60.63% | TRITIUM DCFC LTD's (NASDAQ:DCFC) shares rose 60.63% to $5.85. Shareholders saw the stock price going 73.62% lower in the past month. |
| HOLO | 45.98% | MICROCLOUD HOLOGRAM INC (NASDAQ:HOLO) rose 45.98% to $3.27 during Thursday's pre-market session. In the last month the stock lost 54.75%. |
| HOLOW | 38.0% | During Thursday's pre-market session, GOLDEN PATH ACQ -CW28 (NASDAQ:HOLOW) exhibited strong growth, with the stock price climbing 38.0% to $0.1. Also in the previous session NASDAQ:HOLOW had a very good day: shares closed with a 11.11% gain. |
| ME | 37.62% | During Thursday's pre-market session, 23ANDME HOLDING CO -CLASS A (NASDAQ:ME) experienced a 37.62% increase, with the stock price reaching $0.49. Earlier today the company had a press release: 23andMe announces CEO’s intention to pursue a potential take-private. |
| SINT | 37.0% | The pre-market session on Thursday saw a significant rise in SINTX TECHNOLOGIES INC's (NASDAQ:SINT) shares, climbing 37.0% to $0.05. Today's pre-market session builds upon the previous day's success, as NASDAQ:SINT continues its upward trajectory following a 62.88% gain. |
| THCH | 21.15% | The pre-market session on Thursday saw a significant rise in TH INTERNATIONAL LTD/CAYMAN's (NASDAQ:THCH) shares, climbing 21.15% to $1.26. Earlier today the company had a press release: Tims China Announces Fourth Quarter and Full Year 2023 Financial Results. |
| OMGA | 18.2% | OMEGA THERAPEUTICS INC (NASDAQ:OMGA) experienced an impressive 18.2% increase in share price, reaching $3.02 during the pre-market session on Thursday. In the last month the stock lost 25.51%. |
| LGHL | 17.16% | LION GROUP HOLDING LTD-S ADR's (NASDAQ:LGHL) shares surged 17.16% to reach $0.92 during the pre-market session on Thursday. In the last 3 months the share price dropped with 20.29%. |
For the full premarket gainers list go to our premarket gainers page.
Pre-market losers
| Ticker | Change | Comment |
|---|---|---|
| BBA.W | -55.32% | Investors observed a 55.32% decline in BIGBEAR.AI HOLDINGS -CW28's (NYSE:BBA.W) stock price, which now stands at $0.1 during Thursday's pre-market session. The stock is trading 44.41% lower than a month ago. |
| STKS | -35.28% | ONE GROUP HOSPITALITY INC/TH's (NASDAQ:STKS) stock price is declining with 35.28% to a price of $3.43. The stock is trading 22.69% higher than a month ago. |
| LAC | -25.49% | During Thursday's pre-market session, the shares of LITHIUM AMERICAS CORP (NYSE:LAC) declined by 25.49%, reaching $4.94. Yesterday the company had a press release: Lithium Americas Announces Proposed Public Offering of Common Shares. |
| NRXP | -22.49% | During Thursday's pre-market session, the shares of NRX PHARMACEUTICALS INC (NASDAQ:NRXP) declined by 22.49%, reaching $3.24. Yesterday the company had a press release: New Data on Infection Avoidance and Development of pH Neutral Ketamine, for Intravenous and Subcutaneous Use: NRx Pharmaceuticals (Nasdaq: NRXP). |
| SNGX | -21.25% | SOLIGENIX INC's (NASDAQ:SNGX) shares fell 21.25% to $0.4 during Thursday's pre-market session. In the last year the share price dropped with 66.45%. |
| CAN | -21.0% | The pre-market session on Thursday witnessed a 21.0% decrease in CANAAN INC's (NASDAQ:CAN) shares, with the stock price falling to $0.88. Shareholders saw the stock price going 38.33% lower in the past 3 months. |
| INVO | -19.23% | The stock price of INVO BIOSCIENCE INC (NASDAQ:INVO) is experiencing a decline of 19.23%, reaching $1.47 in today's pre-market session on Thursday. Despite a promising gain of 139.0% yesterday, NASDAQ:INVO faces downward pressure with a 19.23% decline in today's pre-market session. |
| ICUCW | -16.67% | During Thursday's pre-market session, the shares of LMF ACQUISITION OPP -A -CW26 (NASDAQ:ICUCW) declined by 16.67%, reaching $0.1. In the last 3 months the share price increased with 125.0%. |
| JAGX | -14.92% | The pre-market session on Thursday witnessed a 14.92% decrease in JAGUAR HEALTH INC's (NASDAQ:JAGX) shares, with the stock price falling to $0.14. In the last month the stock gained 139.0%. |
| TPET | -14.76% | TRIO PETROLEUM CORP's (NYSEARCA:TPET) shares experienced a 14.76% decline, falling to $0.29 during Thursday's pre-market session. The negative momentum from yesterday's -30.31% drop spilled over into today's pre-market session, with NYSEARCA:TPET recording an additional decline of 14.76%. |
Our premarket losers page will show you the full list.
OMEGA THERAPEUTICS INC
NASDAQ:OMGA (5/6/2024, 7:19:07 PM)
After market: 2.26 -0.02 (-0.88%)2.28
-0.3 (-11.63%)
OMGA News
15 hours ago - InvestorPlaceOMGA Stock Earnings: Omega Therapeutics Misses EPS, Beats Revenue for Q1 2024OMGA stock results show that Omega Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
15 hours ago - BusinessInsiderOMGA Stock Earnings: Omega Therapeutics Misses EPS, Beats Revenue for Q1 2024InvestorPlace - Stock Market News, Stock Advice & Trading Tips Omega Therapeutics (NASDAQ:OMGA) just reported results for the first quarter of...
a day ago - Omega TherapeuticsOmega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressAdvanced MYCHELANGELO™ I trial dose escalation to Cohort 5; Presentation of additional monotherapy data and planned expansion into Phase 2 settings...
14 days ago - Omega TherapeuticsOmega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual MeetingCAMBRIDGE, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering...
19 days ago - ChartmillCurious about the stocks that are showing activity before the opening bell on Thursday?Which stocks are moving before the opening bell on Thursday?
a month ago - Omega TherapeuticsOmega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic ControlMYC-directed epigenomic controller exerts anti-tumor effect in preclinical models of EGFR inhibitor-resistant NSCLC regardless of underlying resistance...
a month ago - InvestorPlaceOMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q4 2023OMGA stock results show that Omega Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
a month ago - BusinessInsiderOMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips Omega Therapeutics (NASDAQ:OMGA) just reported results for the fourth quarter o...
a month ago - Omega TherapeuticsOmega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
